Inhibition of Akt with small molecules and biologics: historical perspective and current status of the patent landscape
- 2 June 2011
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Patents
- Vol. 21 (9) , 1309-1338
Abstract
Introduction: Akt plays a pivotal role in cell survival and proliferation through a number of downstream effectors; unregulated activation of the PI3K/PTEN/Akt pathway is a prominent feature of man...Keywords
This publication has 133 references indexed in Scilit:
- Development of sulfonamide AKT PH domain inhibitorsBioorganic & Medicinal Chemistry, 2011
- Akt-Dependent and Isoform-Specific Regulation of Dopamine Transporter Cell Surface ExpressionACS Chemical Neuroscience, 2010
- Antipsychotic Drugs Activate the C. elegans Akt Pathway via the DAF-2 Insulin/IGF-1 ReceptorACS Chemical Neuroscience, 2010
- DISC1 Regulates New Neuron Development in the Adult Brain via Modulation of AKT-mTOR Signaling through KIAA1212Neuron, 2009
- Antitumor activity of a novel antisense oligonucleotide against Akt1Journal of Cellular Biochemistry, 2009
- Inhibitor hijacking of Akt activationNature Chemical Biology, 2009
- Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agentsJournal of Cell Biology, 2008
- Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesisNature Reviews Cancer, 2006
- Mutation ofPten/Mmac1in mice causes neoplasia in multiple organ systemsProceedings of the National Academy of Sciences, 1999
- High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in miceCurrent Biology, 1998